MétaCan
Menu
Back to cohort
Record W4415675605 · doi:10.1016/j.ard.2025.10.002

EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis

2025· article· en· W4415675605 on OpenAlexaff
Helena Marzo‐Ortega, Stephanie R Harrison, G. Fragoulis, Xabier Michelena, Cristina Macía‐Villa, Sibel Zehra Aydın, Andra Bălănescu, Heidi Bertheussen, Christine Bundy, Maria Sole Chimenti, Paolo Gisondi, Bente Glintborg, Laure Gossec, Umut Kalyoncu, Ennio Lubrano, György Nagy, Wendy Wagenaar, L. Puig, Rubén Queiró, Proton Rahman, Russka Shumnalieva, Enrique R. Soriano, Filip Van den Bosch, Alexandre Sepriano, Pedro Machado, Stefan Siebert

Bibliographic record

VenueAnnals of the Rheumatic Diseases · 2025
Typearticle
Languageen
FieldMedicine
TopicSpondyloarthritis Studies and Treatments
Canadian institutionsMemorial University of NewfoundlandOttawa HospitalUniversity of Ottawa
FundersLeeds Biomedical Research CentreSamsungSwedish Orphan BiovitrumEuropean League Against RheumatismUniversity College London Hospitals NHS Foundation TrustCelltrionTeijin PharmaNational Institute for Health and Care ResearchTeva Pharmaceutical IndustriesCelgeneBiogenAmgenPfizerUniversity College LondonAstraZenecaEli Lilly and CompanyBristol-Myers Squibb
KeywordsPsoriatic arthritisMEDLINEDiseaseArthritisAlternative medicinePsoriasisConsensus conference

Abstract

fetched live from OpenAlex

OBJECTIVES: This study aimed to develop evidence-based points to consider (PtC) and consensus definitions of difficult-to-manage (D2M) and treatment-refractory (TR) psoriatic arthritis (PsA). METHODS: A multidisciplinary international European Alliance of Associations for Rheumatology (EULAR) task force (TF) of 27 members, including rheumatologists, dermatologists, health practitioners, and patient partners, was established, and the EULAR standardised operating procedures, including a systematic literature review and a consensus process, were followed. RESULTS: The TF formulated 4 overarching principles addressing the proportion of patients with PsA with an unsatisfactory treatment response despite the best standard of care, and for which the causes are likely multifactorial. Six PtC highlight criterion relevant for subsequent definitions including failure to achieve or maintain response to ≥2 biological/targeted synthetic disease-modifying antirheumatic drugs with ≥2 different mechanisms of action; management of signs and symptoms perceived as problematic by the rheumatologist and/or the patient, and evidence of persistent disease activity in the presence of extramusculoskeletal manifestations and/or comorbidities and/or objective evidence of inflammatory activity. Finally, the following 2 definitions were developed: (1) D2M PsA, an umbrella term including drivers such as inflammation, comorbidities, psychosocial or other factors, incorporating (2) TR PsA, defined by persistent disease activity and objective evidence of active inflammation. CONCLUSIONS: EULAR proposes 2 consensus definitions to identify a D2M PsA population, including a TR subgroup. These definitions should now be tested in research studies to understand disease pathogenesis and improve care for people living with PsA.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.119
metaresearch head score (Gemma)0.157
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.119
Threshold uncertainty score0.628

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1190.157
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.007
Bibliometrics0.0130.006
Science and technology studies0.0030.004
Scholarly communication0.0070.006
Open science0.0090.010
Research integrity0.0070.008
Insufficient payload (model declined to judge)0.0030.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.328
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAnnals of the Rheumatic DiseasesSame topicSpondyloarthritis Studies and TreatmentsFrench-language works237,207